The steady rise in filings reflects ongoing legal activity, as individuals who used GLP-1 receptor agonist medications (including Ozempic, Wegovy, Rybelsus, Saxenda, and Mounjaro) continue to file lawsuits alleging severe gastrointestinal injuries, including gastroparesis, intestinal blockages, and other digestive complications
Tyrosine kinase inhibitors with inhibitory effects on VEGF prevent tumor angiogenesis, resulting in significant hypoxia in the tumor
Obesity medications take center stage If youre like many who come to Wellstar, youve heard about injectable medications like Wegovy and others
The high cost and large potential patient population for GLP-1 medications threaten the budgets of insurers and states
Once-weekly semaglutide 7.2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial
It turns out that the pink salt trick is more hype than health